21 results
8-K
EX-3.1
RVNC
Revance Therapeutics Inc
15 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:04pm
confidentiality, corporate governance, conflict of interest, Regulation FD, code of conduct and ethics, and stock ownership and trading policies
PRE 14A
pw3ugvbc
12 Mar 21
Preliminary proxy
4:13pm
10-K
19b dqwxctfoc9i
28 Mar 14
Annual report
12:00am
424B4
b98lc
6 Feb 14
Prospectus supplement with pricing info
12:00am
S-1
klx5 p3j9
31 Dec 13
IPO registration
12:00am